Innate Immune Signaling Modulation
We investigate inhibition and activation across endosomal TLR, MyD88 and NLRP3 pathways in inflammation and immune response.
Explore this scienceS&K Therapeutics · Suwon, South Korea
Developing therapeutics for immune modulation and tissue regeneration
We develop small molecules, DNA aptamers and peptides by connecting computational molecular design with experimental biology.
S&KTherapeutics
Immune
Signaling
Signaling
Peptide
Biology
Biology
Molecular
Design
Design
Small
Molecules
Molecules
DNA
Aptamers
Aptamers
Therapeutic
Innovation
Innovation
Innate Immune SignalingRegenerative PeptidesComputational Design
Our research01 02
Two research areas. One disciplined approach
Each program begins with a defined biological question and advances through evidence appropriate to its stage.
Regenerative Peptide Therapeutics
We develop receptor-directed peptides for tissue repair, angiogenesis and recruitment of the body's own stem cells.
Explore this scienceEvidence, clearly defined
From molecular rationale to experimental proof
Our portfolio includes candidates evaluated in cellular studies and programs with animal proof of concept. Evidence levels describe the experiments supporting a program—not completion of clinical-enabling development.
View program evidenceCollaborationExplore partnering →
Advance the next research step with us
We welcome discussions with pharmaceutical companies, biotechnology teams and academic investigators.
Start with a scientific question
Discuss program-specific evidence, translational questions and opportunities for research collaboration, co-development or licensing.